CXCR4+-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis
Author(s) -
Olivia CanoGarrido,
María Virtudes Céspedes,
Ugutz Unzueta,
Paolo Saccardo,
Mònica Roldán,
Alejandro SánchezChardi,
Rafael Cubarsí,
Esther Vázquez,
Ramón Mangues,
Elena GarcíaFruitós,
Antonio Villaverde
Publication year - 2016
Publication title -
nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 109
eISSN - 1748-6963
pISSN - 1743-5889
DOI - 10.2217/nnm-2016-0200
Subject(s) - lactococcus lactis , biodistribution , in vivo , escherichia coli , biofabrication , chemistry , internalization , bacteria , in vitro , cell , biology , biochemistry , microbiology and biotechnology , lactic acid , tissue engineering , genetics , gene
Aim: Lactococcus lactis is a Gram-positive (endotoxin-free) food-grade bacteria exploited as alternative to Escherichia coli for recombinant protein production. We have explored here for the first time the ability of this platform as producer of complex, self-assembling protein materials. Materials & methods: Biophysical properties, cell penetrability and in vivo biodistribution upon systemic administration of tumor-targeted protein nanoparticles produced in L. lactis have been compared with the equivalent material produced in E. coli. Results: Protein nanoparticles have been efficiently produced in L. lactis, showing the desired size, internalization properties and biodistribution. Conclusion: In vitro and in vivo data confirm the potential and robustness of the production platform, pointing out L. lactis as a fascinating cell factory for the biofabrication of protein materials intended for therapeutic applications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom